Advertisement
Image

Global Chronic Obstructive Pulmonary Disease Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Upcoming Report
  • Jun 2021
  • Global
  • 350 Pages
  • No of Tables:
  • No of Figures:
  • Healthcare
  • Upcoming Report
  • Jun 2021
  • Global
  • 350 Pages
  • No of Tables:
  • No of Figures:

Global Chronic Obstructive Pulmonary Disease Market, By Type (Chronic Bronchitis, Emphysema), Treatment Type (Drugs, Surgery, Oxygen Therapy), End User (Hospitals, Clinics, Homecare Settings, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028

Chronic Obstructive Pulmonary Disease MarketMarket Analysis and Insights of Chronic Obstructive Pulmonary Disease

The chronic obstructive pulmonary disease market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 16.00 billion by 2028 and will grow at a CAGR of 4.11% in the above mentioned forecast period.

Chronic Obstructive Pulmonary Disease (COPD) is a type of chronic inflammatory lung disease which causes difficulty in airflow from the lungs. Various symptoms of COPD consist of difficulty in breathing, production of mucus, cough and wheezing.

The rise in the cases of COPD among population across the globe is amongst the important factor expected to intensify the growth and demand of chronic obstructive pulmonary disease market. In addition, the rise in consumption of tobacco among youth population and increase in the awareness among population about the use of generic drug are also expected contributes to the growth in the global market over the forecast period of 2021 to 2028. Also the rise in the expenditure on healthcare is providing facilities in developing countries for chronic obstructive pulmonary disease and rise in awareness among people across developing and underdeveloped are also likely to enhance the growth of the market. Furthermore, the increase in the R&D investment by government and major players are also one of the significant factors expected to fuel the growth of the chronic obstructive pulmonary disease market.                                                                                                                          

The rapid technological advancements and new product launches along with the high demand for home care therapeutic devices are anticipated to offer significant growth opportunities for the market in the forecast period of 2021 to 2028.

However, the stringent government regulations and high cost of chronic obstructive pulmonary disease treatment are expected to curb the growth of the chronic obstructive pulmonary disease market, whereas the lack of awareness and knowledge among population regarding COPD symptoms and indications can challenge the growth of the chronic obstructive pulmonary disease market.

This chronic obstructive pulmonary disease market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the chronic obstructive pulmonary disease market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Chronic Obstructive Pulmonary Disease Market Scope and Market Size

The chronic obstructive pulmonary disease market is segmented on the basis of type, treatment type and end user. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • Based on type, the chronic obstructive pulmonary disease market is segmented into chronic bronchitis and emphysema.
  • On the basis of treatment type, the chronic obstructive pulmonary disease market is segmented into drugs, surgery and oxygen therapy. Drugs have further been segmented into bronchodilator monotherapy and anti-inflammatory drugs. Bronchodilator monotherapy has further been sub-segmented into short-acting beta2-agonists (SABAs), long-acting beta2-agonists (LABAs) and anti-cholinergic agents. Anti-inflammatory drugs have further been sub-segmented into oral and inhaled corticosteroids and anti-leukotrienes. Surgery has further been segmented into lung volume reduction surgery (LVRS), lung transplant, bullectomy and others.
  • On the basis of end user, the chronic obstructive pulmonary disease market is segmented into hospitals, clinics, homecare settings and others.

Chronic Obstructive Pulmonary Disease Market Country Level Analysis

The chronic obstructive pulmonary disease market is analyzed and market size insights and trends are provided by country, type, treatment type and end user as referenced above.

The countries covered in the chronic obstructive pulmonary disease market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.

North America region leads the chronic obstructive pulmonary disease market owing to the rise in the patient population suffering from COPD and the strong presence of major market players. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the rise in the patient population suffering from COPD and the high prevalence of respiratory disease. 

The country section of the chronic obstructive pulmonary disease market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The chronic obstructive pulmonary disease market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for chronic obstructive pulmonary disease market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the chronic obstructive pulmonary disease market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Chronic Obstructive Pulmonary Disease Market Share Analysis

The chronic obstructive pulmonary disease market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to chronic obstructive pulmonary disease market.

The major players covered in the chronic obstructive pulmonary disease market report are AstraZeneca, Boehringer Ingelheim International GmbH, GlaxoSmithKline plc, Novartis AG, CHIESI Farmaceutici SpA, Sunovion Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd, Mylan N.V., Orion Corporation, Merck & Co., Inc, Grifols, S.A., Abbott, F. Hoffmann-La Roche Ltd, Vectura Group plc, Pfizer Inc, Alkermes, Mylan N.V, Almirall, S.A, Genentech, Inc, Biogen, and Astellas Pharma Inc.,  among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.


SKU-
Why Choose Us
Flowers


Frequently Asked Questions